Приказ основних података о документу

MIF in autoimmunity and novel therapeutic approaches

dc.creatorStošić-Grujičić, Stanislava
dc.creatorStojanović, Ivana D.
dc.creatorNicoletti, Ferdinando
dc.date.accessioned2017-11-23T11:12:37Z
dc.date.available2015-11-17T10:26:51Z
dc.date.issued2009sr
dc.identifier.issn1568-9972sr
dc.identifier.otherRad_konverzija_3461sr
dc.identifier.urihttps://radar.ibiss.bg.ac.rs/handle/123456789/1466
dc.description.abstractMacrophage migration inhibitory factor (MIF) is a multipotent cytokine implicated in the pathogenesis of numerous inflammatory and autoimmune disorders. Since anti-cytokine therapy is considered to be a promising therapeutic strategy, selective targeting of MIF with either anti-MIF antibody or specific chemical MIF inhibitors might offer new therapeutic avenues for these disorders. Considering the unique relationship between MIF and glucocorticoids, therapeutic antagonism of MIF could also represent an effective approach for steroid-sparing therapies in patients with refractory autoimmune diseases. (c) 2008 Elsevier B.V. All rights reserved.en
dc.description.sponsorshipSerbian Ministry of Science [143029]sr
dc.language.isoEnglishsr
dc.rightsrestrictedAccess
dc.sourceAutoimmunity Reviewssr
dc.titleMIF in autoimmunity and novel therapeutic approachesen
dc.typearticle
dc.rights.licenseARR
dcterms.abstractСтојановић, Ивана Т; Стошић-Грујичић, Станислава Д.; Ницолетти, Фердинандо;
dc.citation.issue3sr
dc.citation.volume8sr
dc.citation.epage249sr
dc.type.versionpublishedVersionen
dc.citation.rankM21
dc.identifier.rcubhttps://hdl.handle.net/21.15107/rcub_ibiss_1466


Документи

ДатотекеВеличинаФорматПреглед

Уз овај запис нема датотека.

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу